FEATURE ARTICLES
Advanced manufacturing technologies (AMTs) can not only lower costs but also improve the quality and consistency of both API and final dosage manufacturing in pharmaceuticals, so why are they not more widely implemented?
- 4 Centralized Comparator Sourcing Models To Fortify Supply Chains
- Can AMTs Make U.S. Pharmaceuticals Faster, Better, Stronger?
- Preparing For FDA's Expanded Use Of Unannounced Inspections At Foreign Manufacturing Facilities
- Pharma Enterprise Resource Planning: From Automation To AI-Driven Insights
- Managing Extractables And Leachables In HPAPI Manufacturing
- Unlocking Value In Biopharma Operations: A C-Suite Call To Action
- Audit Trail Compliance And What To Look For In Mitigation Software
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1337837329 regulatory, paperwork, writing]( "Perspectives On Performance, Scalability, And Regulatory Compliance")
Perspectives On Performance, Scalability, And Regulatory ComplianceHere, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.
-
Inspecting On The Edge — Understanding Punch Tip Wear7/30/2024
Why is a horizontal optical comparator highly recommended for tablet manufacturers as a measuring tool for punch tip inspection, and what strategies can be used to detect, reduce, and prevent tip wear?
-
Connecting Quality Management, Patient-Centricity, And Business Value2/18/2025
Examine why organizations must integrate data and processes to enhance quality and insights to improve operational efficiency, patient health, and regulatory compliance.
-
Topliss Sets In Drug Design Technical Notes For The Medicinal Chemist8/3/2023
When considering new, innovative, and efficient drug design processes, you may want to review Professor J G Topliss's non-mathematical operational schemes for analogue design.
-
Supplier Quality Is Only As Strong As Your Weakest Link2/5/2025
Your supply chain is only as strong as its weakest link. 52% of organizations attribute recalls to supplier-related issues, and proactive supplier quality management is essential to protect your brand.
-
Navigating The FDA's Drug Supply Chain Security Act3/14/2025
Explore the transformative impact of the DSCSA on the pharmaceutical industry, which ensures stringent standards, prevents counterfeit drugs, and enhances traceability for both large corporations and small manufacturers.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Getting CMC Right For Emerging Technologies
- Cell Therapy Facility For DTM At NIH Clinical Center
- PPQ: Early Adoption Of Digital Process Systems Puts You In Control
- Direct And Rapid Multi-Attribute Monitoring Of Intact Monoclonal Antibodies By icIEF-UV/MS
- Asset Reinduction To Maximo EAM, Enabled By Reality Capture
NEWSLETTER ARCHIVE
- 07.18.25 -- A Look At Elsa, The FDA's New AI Digital Assistant
- 07.17.25 -- Bracing For The Impact Of The Federal Workforce Reduction
- 07.17.25 -- STREAM Edition: Reducing Costs, Making Peptide Synthesis Greener
- 07.16.25 -- Breaking Barriers: 3D Screen Printing Transforms Drug Formulation
- 07.16.25 -- Innovation driving access in advanced therapies
INDUSTRY NEWS
-
![FDA Approved GettyImages-1215516118]( "FDA Publishes 200+ CRLs For Increased Transparency")
FDA Publishes 200+ CRLs For Increased TransparencyThe letters were made available to increase transparency and help sponsors reduce similar mistakes in the future.
-
![White Tablets-GettyImages-172969989]( "Researchers Switch Up Paracetamol Production With Eco Method")
Researchers Switch Up Paracetamol Production With Eco MethodScientists at the University of Edinburgh’s Wallace Lab developed a method to produce paracetamol that can reduce environmental pollution and the industry’s reliance on fossil fuels
-
![FDA Approved stamp-GettyImages-2196512628]( "FDA Addresses U.S. Health Crisis With Voucher Program")
FDA Addresses U.S. Health Crisis With Voucher ProgramFDA Commissioner Marty Makary, M.D., M.P.H., tapped into his oncologist experience to launch a new FDA program designed to fast-track the time it takes for important drugs to receive approval and get to patients.
-
![Scientists working in lab-GettyImages-542935478]( "Lab Oversupply Is Pushing Leasing, Rent and Relocation Down")
Lab Oversupply Is Pushing Leasing, Rent and Relocation DownThe landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.
-
![US Food and Drug-GettyImages-2200850893]( "CDER's Director Set To Retire Amid FDA Leadership Shuffle")
CDER's Director Set To Retire Amid FDA Leadership ShuffleJacqueline Corrigan-Curay, M.D., J.D., announced plans to retire from her position as acting director of CDER, calling the decision "incredibly challenging." Corrigan-Curay is not alone in her decision to leave the FDA, with a number of leaders exiting the agency since January.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Short Notice Auction: Solid Dose Equipment For CMO, CDMO Operations7/18/2025
Federal Equipment Company is hosting a short notice auction featuring essential pharmaceutical solid dose equipment—ideal for contract manufacturers and development organizations (CMOs & CDMOs). This auction runs from July 25-30, 2025 and offers premium assets to support formulation, scale-up, and production workflows.
-
Amphastar Pharmaceuticals Announces Multi-Year Expansion Of US Manufacturing Operations In California7/18/2025
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), a bio-pharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, has announced a multi-year expansion of its U.S. manufacturing operations at its headquarters in Rancho Cucamonga, California. The company plans to quadruple its production capacity at this location over the next three to five years, reinforcing its commitment to domestic pharmaceutical manufacturing and strengthening supply chain resilience.
-
GenesisM Breaks Ground On 154,000 Square Foot Biomanufacturing Facility In Greater Boston Area7/18/2025
GenesisM, a joint venture between Bain Capital Real Estate ("Bain Capital") and Botanic Properties ("Botanic"), today announced the official groundbreaking of its 154,000-square-foot Class A biomanufacturing facility at 45 Crosby Drive in Bedford, Massachusetts. The groundbreaking ceremony was attended by members of the project team, town officials and representatives, and local partners in the biotech and real estate communities.
-
Natoli Engineering Introduces 2D And 3D Imaging Solution For Visualize Tablets Effectively7/18/2025
Natoli Engineering, a globally recognized innovator in the tablet compression industry, proudly introduces the Precision CT Scan. This innovative 2-D and 3-D imaging solution provides non-destructive analysis that allows manufacturers to visualize internal tablet structures without cutting or altering them, helping detect flaws early and avoid costly problems. Early flaw detection helps maintain quality, ensure compliance, and protect manufacturers’ reputations.
-
Thermo Fisher Scientific To Acquire Sanofi's Sterile Fill/Finish Drug Manufacturing And Packaging Facility In New Jersey7/16/2025
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product manufacturing. The terms of the deal were not disclosed.
